Literature DB >> 21827883

Neuropathology of degenerative ataxias.

Jonathan D Fratkin1, P J S Vig.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 21827883     DOI： 10.1016/B978-0-444-51892-7.00005-X

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN： 0072-9752


× No keyword cloud information.
  9 in total

1.  Longitudinal study of cognitive and psychiatric functions in spinocerebellar ataxia types 1 and 2.

Authors:  Roberto Fancellu; Dominga Paridi; Chiara Tomasello; Marta Panzeri; Anna Castaldo; Silvia Genitrini; Paola Soliveri; Floriano Girotti
Journal:  J Neurol       Date:  2013-12       Impact factor: 4.849

2.  Changes in CB(1) and CB(2) receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias.

Authors:  Carmen Rodríguez-Cueto; Cristina Benito; Javier Fernández-Ruiz; Julián Romero; Mariluz Hernández-Gálvez; María Gómez-Ruiz
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

3.  Vascular risk factors and clinical progression in spinocerebellar ataxias.

Authors:  Raymond Y Lo; Karla P Figueroa; Stefan M Pulst; Chi-Ying Lin; Susan Perlman; George Wilmot; Christopher M Gomez; Jeremy Schmahmann; Henry Paulson; Vikram G Shakkottai; Sarah H Ying; Theresa Zesiewicz; Khalaf Bushara; Michael Geschwind; Guangbin Xia; S H Subramony; Tetsuo Ashizawa; Sheng-Han Kuo
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2015-02-02

4.  Altered striatal endocannabinoid signaling in a transgenic mouse model of spinocerebellar ataxia type-3.

Authors:  Carmen Rodríguez-Cueto; Mariluz Hernández-Gálvez; Cecilia J Hillard; Patricia Maciel; Sara Valdeolivas; José A Ramos; María Gómez-Ruiz; Javier Fernández-Ruiz
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240

Review 5.  Endocannabinoid System in Spinocerebellar Ataxia Type-3 and Other Autosomal-Dominant Cerebellar Ataxias: Potential Role in Pathogenesis and Expected Relevance as Neuroprotective Targets.

Authors:  María Gómez-Ruiz; Carmen Rodríguez-Cueto; Eva Luna-Piñel; Mariluz Hernández-Gálvez; Javier Fernández-Ruiz
Journal:  Front Mol Neurosci       Date:  2019-04-24       Impact factor: 5.639

6.  Suppression of Mutant Protein Expression in SCA3 and SCA1 Mice Using a CAG Repeat-Targeting Antisense Oligonucleotide.

Authors:  Eleni Kourkouta; Rudie Weij; Anchel González-Barriga; Melissa Mulder; Ruurd Verheul; Sieto Bosgra; Bas Groenendaal; Jukka Puoliväli; Jussi Toivanen; Judith C T van Deutekom; Nicole A Datson
Journal:  Mol Ther Nucleic Acids       Date:  2019-07-19       Impact factor: 8.886

7.  LMNB1-Related Adult-Onset Autosomal Dominant Leukodystrophy Presenting as Movement Disorder: A Case Report and Review of the Literature.

Authors:  Yanyan Zhang; Jie Li; Rong Bai; Jianping Wang; Tao Peng; Lijie Chen; Jingtao Wang; Yanru Liu; Tian Tian; Hong Lu
Journal:  Front Neurosci       Date:  2019-10-21       Impact factor: 4.677

8.  Postural Tremor and Ataxia Progression in Spinocerebellar Ataxias.

Authors:  Shi-Rui Gan; Jie Wang; Karla P Figueroa; Stefan M Pulst; Darya Tomishon; Danielle Lee; Susan Perlman; George Wilmot; Christopher M Gomez; Jeremy Schmahmann; Henry Paulson; Vikram G Shakkottai; Sarah H Ying; Theresa Zesiewicz; Khalaf Bushara; Michael D Geschwind; Guangbin Xia; S H Subramony; Tetsuo Ashizawa; Sheng-Han Kuo
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2017-10-09

9.  Loss of the mitochondrial i-AAA protease YME1L leads to ocular dysfunction and spinal axonopathy.

Authors:  Hans-Georg Sprenger; Gulzar Wani; Annika Hesseling; Tim König; Maria Patron; Thomas MacVicar; Sofia Ahola; Timothy Wai; Esther Barth; Elena I Rugarli; Matteo Bergami; Thomas Langer
Journal:  EMBO Mol Med       Date:  2019-01       Impact factor: 12.137
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.